Cell Therapy Technologies Market by Product (Consumables, Equipment (Single-Use Equipment, Other Equipment), Systems & Software), Process (Cell Processing), Cell Type (T-cells, Stem Cells), End User (Research Institutes) - Global Forecast to 2025

細胞治療技術の世界市場予測(~2025):製品別、プロセス別、細胞種類別、エンドユーザー別

◆タイトル:Cell Therapy Technologies Market by Product (Consumables, Equipment (Single-Use Equipment, Other Equipment), Systems & Software), Process (Cell Processing), Cell Type (T-cells, Stem Cells), End User (Research Institutes) - Global Forecast to 2025
◆商品コード:BT 6823
◆調査・発行会社:MarketsandMarkets
◆発行日:2020年10月28日
◆ページ数:168
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥514,800見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥691,600見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥847,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

MarketsandMarkets社は細胞治療技術の世界市場が2020年28億ドルから2025年56億ドルまで、年平均14.4%成長すると予想しています。本調査レポートでは、細胞治療技術の世界市場について調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、製品別(消耗品、機器、システム・ソフトウェア)分析、プロセス別(細胞加工、細胞保存・分配・ハンドリング、プロセス監視・品質管理)分析、細胞種類別(T細胞、幹細胞、その他細胞)分析、エンドユーザー別(バイオ医薬品・バイオテクノロジー企業・クロス、研究機関・細胞バンク)分析、地域別分析、競争状況・企業情報などの項目を掲載しています。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・細胞治療技術の世界市場規模:製品別(消耗品、機器、システム・ソフトウェア)
・細胞治療技術の世界市場規模:プロセス別(細胞加工、細胞保存・分配・ハンドリング、プロセス監視・品質管理)
・細胞治療技術の世界市場規模:細胞種類別(T細胞、幹細胞、その他細胞)
・細胞治療技術の世界市場規模:エンドユーザー別(バイオ医薬品・バイオテクノロジー企業・クロス、研究機関・細胞バンク)
・細胞治療技術の世界市場規模:地域別
・競争状況・企業情報

“The global cell therapy technologies market is projected to reach USD 5.6 billion by 2025 from USD 2.8 billion in 2020, at a CAGR of 14.4% from 2020 to 2025.”
The growth of this market is driven by the rising government investments in cell-based research, increasing incidence of chronic and infectious diseases, large number of oncology-related cell therapy clinical trials, and increasing GMP certifications for cell therapy production facilities. Also, the emergence of iPSCs as an alternative to ESCs and increased focus on personalized medicine to offer an opportunity for the growth of the market during the forecast period.

“Consumables is expected to hold the largest share of the cell therapy technologies market, by product in 2020.”
On the basis of product, the market is segmented into consumables, equipment, and systems & software. The consumables segment accounted for the largest share of the cell therapy technologies market in 2019. Factors such as increasing investments by companies to develop advanced products as well as government initiatives for enhancing cell-based research are contributing to the growth of the cell therapy consumables market.

“T-cells is expected to hold the largest share of the cell therapy technologies market, in 2020.”
On the basis of cell type, the market is segmented into, T-cells, stem cells, and other cells. In 2019, T-cells accounted for the largest share of the cell therapy technologies market. Favorable government initiatives and the increasing demand for T-cell therapies are the key factors driving the growth of this segment.

“Cell processing is expected to hold the largest share of the cell therapy technologies market in 2020.”
On the basis of process, the market is segmented into cell processing, cell preservation, distribution and handling, and process monitoring and quality control. The cell processing segment dominated the market in 2019. This segment is expected to grow at the highest CAGR during the forecast period. The cell processing stage makes the highest use of cell therapy instruments and media, especially during culture media processing. This is the major factor responsible for the large share and high growth of this segment.

“Biopharmaceutical & biotechnology companies and CROs segment commanded the largest share of the cell therapy technologies market in 2020.”
By end user, the cell therapy technologies market is segmented into biopharmaceutical & biotechnology companies and CROs and research institutes and cell banks. Biopharmaceutical & biotechnology companies and CROs dominate the market and are expected to grow at the highest CAGR. The large share of this regional segment can primarily be attributed to the high burden of chronic diseases and increasing R&D activities in the pharmaceutical and biotechnology industries.

“North America commanded the largest share of the cell therapy technologies market in 2020.”
On the basis of region, the cell therapy technologies market is segmented into North America, Europe, Asia Pacific, and Rest of the World. In 2019, North America commanded the largest share of the cell therapy technologies market. The large share of this market segment can be attributed to the increasing incidence of CVD, increasing healthcare expenditure, growing disposable income, growing healthcare awareness, and the availability of technologically advanced devices in the region.

Breakdown of supply-side primary interviews, by company type, designation, and region:
• By Company Type: Tier 1 (20%) , Tier 2 (45%), and Tier 3 (35%)
• By Designation: C-level (30%), Director-level (20%), and Others (50%)
• By Region: North America (35%), Europe (24%), AsiaPacific (25%), and RoW (16%).

The some of the major players operating in this market are Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany) and Danaher Corporation (US).

List of Companies Profiled in the Report:
• Thermo Fisher Scientific Inc. (US)
• Merck KGaA (Germany)
• MaxCyte (US)
• Danaher Corporation (US)
• Becton, Dickinson and Company (US)
• Lonza Group (Switzerland)
• Sartorius AG (Germany)
• Terumo BCT (US)
• Fresenius Medical Care AG & Co. KGaA (Germany)
• Avantor, Inc. (US)
• Bio-Techne Corporation (US)
• Corning Incorporated (US)
• FUJIFILM Irvine Scientific (US)
• Werum IT Solutions GmbH (Germany)
• RoosterBio Inc. (US)
• SIRION Biotech GmbH (Germany)
• CellGenix GmbH (Germany)
• L7 Informatics, Inc. (US)
• Miltenyi Biotec GmbH (Germany)
• STEMCELL Technologies (Canada)
• Hemasoft (US)
• MAK-SYSTEM (US)
• OrganaBio, LLC (US)
• IxCells Biotechnology (China)
• Wilson Wolf Corporation (US)

Research Coverage:
This report studies the cell therapy technologies market based on product, cell type, process, end user, and region. The report also analyzes factors (such as drivers, restraints, challenges, and opportunities) affecting market growth. It evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total cell therapy technologies market. The report forecasts the revenue of the market segments with respect to four major regions.

Reasons to Buy the Report:
The report provides insights on the following pointers:
• Market Penetration: Comprehensive information on cell therapy technologies offered by the top 25 players in the cell therapy technologies market. The report analyzes the cell therapy technologies market by product, cell type, process, end user, and region.
• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various securement devices across key geographic regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the cell therapy technologies market.
• Competitive Assessment: In-depth assessment of market shares and strategies of the leading players in the cell therapy technologies market.

Frequently asked questions:
• What are the growth opportunities in the cell therapy technologies market across major regions in the future?
• Which type of cells are expected to hold the largest share in the cell therapy technologies market?
• What are the various cell therapy technologies product types and their respective market shares in the overall market?
• Which region has a well-developed cell therapy technologies market?
• What is the impact of COVID-19 on cell therapy technologies market?

【レポートの目次】

1 INTRODUCTION 23
1.1 OBJECTIVES OF THE STUDY 23
1.2 MARKET DEFINITION 23
1.2.1 INCLUSIONS AND EXCLUSIONS 23
1.3 MARKET SCOPE 24
1.3.1 MARKETS COVERED 24
1.3.2 YEARS CONSIDERED FOR THE STUDY 24
1.4 CURRENCY 25
1.5 LIMITATIONS 25
1.6 STAKEHOLDERS 25
1.7 SUMMARY OF CHANGES 25
1.8 LIMITATIONS OF THE CURRENT EDITION 26
2 RESEARCH METHODOLOGY 27
2.1 RESEARCH DATA 27
FIGURE 1 RESEARCH DESIGN 27
2.1.1 SECONDARY DATA 28
2.1.1.1 Key data from secondary sources 28
2.1.2 PRIMARY DATA 29
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,
DESIGNATION, AND REGION 29
2.1.2.1 Key data from primary sources 30
2.2 MARKET SIZE ESTIMATION 30
FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 31
2.2.1 BOTTOM-UP APPROACH 32
FIGURE 4 CELL THERAPY TECHNOLOGIES MARKET: BOTTOM-UP APPROACH 32
2.2.2 GROWTH FORECAST 32
2.2.3 TOP-DOWN APPROACH 32
FIGURE 5 CELL THERAPY TECHNOLOGIES MARKET: TOP-DOWN APPROACH 32
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 33
FIGURE 6 DATA TRIANGULATION METHODOLOGY 33
2.4 ASSUMPTIONS FOR THE STUDY 34
3 EXECUTIVE SUMMARY 35
FIGURE 7 CELL THERAPY TECHNOLOGIES MARKET, BY PRODUCT,
2020 VS. 2025 (USD MILLION) 35
FIGURE 8 CELL THERAPY TECHNOLOGIES MARKET, BY CELL TYPE,
2020 VS. 2025 (USD MILLION) 36
FIGURE 9 CELL THERAPY TECHNOLOGIES MARKET, BY PROCESS,
2020 VS. 2025 (USD MILLION) 36
FIGURE 10 CELL THERAPY TECHNOLOGIES MARKET, BY END USER,
2020 VS. 2025 (USD MILLION) 37
FIGURE 11 CELL THERAPY TECHNOLOGIES MARKET, BY REGION,
2020 VS. 2025 (USD MILLION) 37
4 PREMIUM INSIGHTS 39
4.1 CELL THERAPY TECHNOLOGIES: MARKET OVERVIEW 39
FIGURE 12 LARGE NUMBER OF ONCOLOGY-RELATED CELL THERAPY CLINICAL TRIALS TO DRIVE MARKET GROWTH DURING THE FORECAST PERIOD 39
4.2 ASIA PACIFIC: CELL THERAPY TECHNOLOGIES MARKET, BY PRODUCT 40
FIGURE 13 CONSUMABLES TO DOMINATE THE ASIA PACIFIC CELL THERAPY TECHNOLOGIES MARKET IN 2019 40
4.3 GEOGRAPHICAL SNAPSHOT OF THE CELL THERAPY TECHNOLOGIES MARKET 41
FIGURE 14 CHINA TO REGISTER THE HIGHEST GROWTH RATE DURING
THE FORECAST PERIOD 41
5 MARKET OVERVIEW 42
5.1 INTRODUCTION 42
5.2 MARKET DYNAMICS 42
FIGURE 15 CELL THERAPY TECHNOLOGIES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 42
5.2.1 DRIVERS 43
5.2.1.1 Rising government investments in cell-based research 43
TABLE 1 NIH FUNDING FOR CELL-BASED RESEARCH, 2016–2019 (USD MILLION) 43
5.2.1.2 Rising incidence of chronic and infectious diseases 44
FIGURE 16 GLOBAL CANCER INCIDENCE, BY REGION, 2018 VS. 2030 44
5.2.1.3 Large number of oncology-related cell therapy clinical trials 45
FIGURE 17 CANCER CELL THERAPY PIPELINE (MARCH 2019–MARCH 2020) 45
5.2.1.4 Increasing GMP certifications for cell therapy production facilities 46
TABLE 2 RISING MANUFACTURING CERTIFICATIONS AND APPROVALS FOR
GMP TO BOOST THE MARKET 46
5.2.2 RESTRAINTS 46
5.2.2.1 High cost of cell-based research and low success rate 46
TABLE 3 COST OF CELL THERAPY EQUIPMENT 47
TABLE 4 BREAKDOWN OF ACTIVE CELL THERAPY CLINICAL TRIALS,
BY CELL GROUP AND TRIAL PHASE 47
5.2.2.2 Dearth of skilled professionals 47
5.2.3 OPPORTUNITIES 47
5.2.3.1 Emergence of iPSCs as an alternative to ESCs 47
5.2.3.2 Increased focus on personalized medicine 48
5.2.3.3 Increasing public-private partnerships for the development
of cell therapies 48
5.2.3.4 Emerging Asian markets 49
5.2.4 CHALLENGES 49
5.2.4.1 Survival of small players and new entrants 49
5.3 VALUE CHAIN ANALYSIS 50
FIGURE 18 VALUE CHAIN ANALYSIS: MAJOR VALUE IS ADDED DURING THE MANUFACTURING AND ASSEMBLY PHASE 50
5.4 SUPPLY CHAIN ANALYSIS 51
FIGURE 19 DIRECT DISTRIBUTION—THE PREFERRED STRATEGY OF
PROMINENT COMPANIES 51
5.5 ECOSYSTEM ANALYSIS 52
FIGURE 20 ECOSYSTEM ANALYSIS OF THE BIOTECHNOLOGY INDUSTRY 52
5.6 COVID-19 IMPACT ANALYSIS 52
5.7 REGULATORY LANDSCAPE 53
5.7.1 NORTH AMERICA 53
TABLE 5 NORTH AMERICA: REGULATORY LANDSCAPE FOR STEM CELL THERAPIES 53
5.7.2 EUROPE 54
TABLE 6 EUROPE: REGULATORY LANDSCAPE FOR STEM CELL THERAPIES 54
5.7.3 ASIA PACIFIC 55
TABLE 7 ASIA PACIFIC: REGULATORY LANDSCAPE FOR STEM CELL THERAPIES 55
5.7.4 ROW 56
TABLE 8 ROW: REGULATORY LANDSCAPE FOR STEM CELL THERAPIES 56
5.8 AVERAGE SELLING PRICE TRENDS 57
TABLE 9 AVERAGE SELLING PRICE OF CELL PROCESSING SYSTEMS,
2019 VS 2023 VS 2025 57
6 CELL THERAPY TECHNOLOGIES MARKET, BY PRODUCT 58
6.1 INTRODUCTION 59
TABLE 10 CELL THERAPY TECHNOLOGIES MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 59
6.2 CONSUMABLES 59
6.2.1 HIGH REQUIREMENT OF CONSUMABLES IN PROCESSES
SUPPORTS MARKET GROWTH 59
TABLE 11 CELL THERAPY CONSUMABLES MARKET, BY REGION,
2018–2025 (USD MILLION) 60
6.3 EQUIPMENT 60
TABLE 12 CELL THERAPY EQUIPMENT MARKET, BY REGION,
2018–2025 (USD MILLION) 60
TABLE 13 CELL THERAPY EQUIPMENT MARKET, BY TYPE, 2018–2025 (USD MILLION) 60
6.3.1 CELL PROCESSING EQUIPMENT 61
6.3.1.1 Cell processing equipment dominates the overall equipment market 61
TABLE 14 CELL PROCESSING EQUIPMENT MARKET, BY REGION,
2018–2025 (USD MILLION) 61
6.3.2 SINGLE-USE EQUIPMENT 61
6.3.2.1 Benefits of single-use equipment have ensured end-user demand 61
TABLE 15 SINGLE-USE EQUIPMENT MARKET, BY REGION, 2018–2025 (USD MILLION) 62
6.3.3 OTHER CELL THERAPY EQUIPMENT 62
TABLE 16 OTHER CELL THERAPY EQUIPMENT MARKET, BY REGION,
2018–2025 (USD MILLION) 62
6.4 SYSTEMS & SOFTWARE 63
6.4.1 SYSTEMS & SOFTWARE ARE USED TO MONITOR THE DIFFERENT STAGES OF CELL PROCESSING 63
TABLE 17 CELL THERAPY SYSTEMS & SOFTWARE MARKET, BY REGION,
2018–2025 (USD MILLION) 63
7 CELL THERAPY TECHNOLOGIES MARKET, BY PROCESS 64
7.1 INTRODUCTION 65
TABLE 18 CELL THERAPY TECHNOLOGIES MARKET, BY PROCESS,
2018–2025 (USD MILLION) 65
7.2 CELL PROCESSING 65
7.2.1 CELL PROCESSING MAKES THE MOST USE OF CELL THERAPY INSTRUMENTS 65
TABLE 19 CELL THERAPY TECHNOLOGIES MARKET FOR CELL PROCESSING, BY REGION, 2018–2025 (USD MILLION) 65
7.3 CELL PRESERVATION, DISTRIBUTION, AND HANDLING 66
7.3.1 INCREASING DEMAND FOR CELL-BASED MEDICAL PRODUCTS AND THERAPIES TO DRIVE THE GROWTH OF THE SEGMENT 66
TABLE 20 CELL THERAPY TECHNOLOGIES MARKET FOR CELL PRESERVATION, DISTRIBUTION, AND HANDLING, BY REGION, 2018–2025 (USD MILLION) 66
7.4 PROCESS MONITORING AND QUALITY CONTROL 66
7.4.1 PROCESS MONITORING IS ESSENTIAL TO ENSURE THE QUALITY AND ACCURACY OF CELL PROCESSING 66
TABLE 21 CELL THERAPY TECHNOLOGIES MARKET FOR PROCESS MONITORING AND QUALITY CONTROL, BY REGION, 2018–2025 (USD MILLION) 67
8 CELL THERAPY TECHNOLOGIES MARKET, BY CELL TYPE 68
8.1 INTRODUCTION 69
TABLE 22 CELL THERAPY TECHNOLOGIES MARKET, BY CELL TYPE,
2018–2025 (USD MILLION) 69
8.2 T-CELLS 69
8.2.1 RESEARCH CONDUCTED IN THE FIELD OF CAR-T THERAPY WILL ACCELERATE THE GROWTH OF THE SEGMENT 69
TABLE 23 T-CELL THERAPY TECHNOLOGIES MARKET, BY REGION,
2018–2025 (USD MILLION) 70
8.3 STEM CELLS 70
8.3.1 INCREASING FUNDING IN STEM CELL RESEARCH TO DRIVE MARKET GROWTH 70
TABLE 24 STEM CELL THERAPY TECHNOLOGIES MARKET, BY REGION,
2018–2025 (USD MILLION) 71
8.4 OTHER CELLS 71
TABLE 25 OTHER CELL THERAPY TECHNOLOGIES MARKET, BY REGION,
2018–2025 (USD MILLION) 71

9 CELL THERAPY TECHNOLOGIES MARKET, BY END USER 72
9.1 INTRODUCTION 73
TABLE 26 CELL THERAPY TECHNOLOGIES MARKET, BY END USER,
2018–2025 (USD MILLION) 73
9.2 BIOPHARMACEUTICAL & BIOTECHNOLOGY COMPANIES AND CROS 73
9.2.1 RISING NUMBER OF CELL THERAPY MANUFACTURING FACILITIES
TO DRIVE THE MARKET 73
TABLE 27 CELL THERAPY TECHNOLOGIES MARKET FOR BIOPHARMACEUTICAL & BIOTECHNOLOGY COMPANIES AND CROS, BY REGION,
2018–2025 (USD MILLION) 74
9.3 RESEARCH INSTITUTES AND CELL BANKS 74
9.3.1 MARKET GROWTH IS SUPPORTED BY RISING RESEARCH ACTIVITY 74
TABLE 28 CELL THERAPY TECHNOLOGIES MARKET FOR RESEARCH INSTITUTES AND CELL BANKS, BY REGION, 2018–2025 (USD MILLION) 75
10 CELL THERAPY TECHNOLOGIES MARKET, BY REGION 76
10.1 INTRODUCTION 77
TABLE 29 CELL THERAPY TECHNOLOGIES MARKET, BY REGION,
2018–2025 (USD MILLION) 77
10.2 NORTH AMERICA 77
FIGURE 21 NORTH AMERICA: CELL THERAPY TECHNOLOGIES MARKET SNAPSHOT 78
TABLE 30 NORTH AMERICA: CELL THERAPY TECHNOLOGIES MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 78
TABLE 31 NORTH AMERICA: CELL THERAPY TECHNOLOGIES MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 79
TABLE 32 NORTH AMERICA: CELL THERAPY EQUIPMENT MARKET, BY TYPE,
2018–2025 (USD MILLION) 79
TABLE 33 NORTH AMERICA: CELL THERAPY TECHNOLOGIES MARKET, BY PROCESS, 2018–2025 (USD MILLION) 79
TABLE 34 NORTH AMERICA: CELL THERAPY TECHNOLOGIES MARKET, BY CELL TYPE, 2018–2025 (USD MILLION) 80
TABLE 35 NORTH AMERICA: CELL THERAPY TECHNOLOGIES MARKET, BY END USER, 2018–2025 (USD MILLION) 80
10.2.1 US 80
10.2.1.1 Increasing R&D activities to support market growth in the US 80
TABLE 36 US: CELL THERAPY TECHNOLOGIES MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 81
TABLE 37 US: CELL THERAPY TECHNOLOGIES MARKET, BY PROCESS,
2018–2025 (USD MILLION) 81
TABLE 38 US: CELL THERAPY TECHNOLOGIES MARKET, BY CELL TYPE,
2018–2025 (USD MILLION) 81
TABLE 39 US: CELL THERAPY TECHNOLOGIES MARKET, BY END USER,
2018–2025 (USD MILLION) 81
10.2.2 CANADA 82
10.2.2.1 Increasing government funding to drive the adoption of cell therapy instruments in Canada 82
TABLE 40 CANADA: CELL THERAPY TECHNOLOGIES MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 82
TABLE 41 CANADA: CELL THERAPY TECHNOLOGIES MARKET, BY PROCESS,
2018–2025 (USD MILLION) 83
TABLE 42 CANADA: CELL THERAPY TECHNOLOGIES MARKET, BY CELL TYPE,
2018–2025 (USD MILLION) 83
TABLE 43 CANADA: CELL THERAPY TECHNOLOGIES MARKET, BY END USER,
2018–2025 (USD MILLION) 83
10.3 EUROPE 84
TABLE 44 EUROPE: CELL THERAPY TECHNOLOGIES MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 84
TABLE 45 EUROPE: CELL THERAPY TECHNOLOGIES MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 84
TABLE 46 EUROPE: CELL THERAPY EQUIPMENT MARKET, BY TYPE,
2018–2025 (USD MILLION) 85
TABLE 47 EUROPE: CELL THERAPY TECHNOLOGIES MARKET, BY PROCESS,
2018–2025 (USD MILLION) 85
TABLE 48 EUROPE: CELL THERAPY TECHNOLOGIES MARKET, BY CELL TYPE,
2018–2025 (USD MILLION) 85
TABLE 49 EUROPE: CELL THERAPY TECHNOLOGIES MARKET, BY END USER,
2018–2025 (USD MILLION) 86
10.3.1 GERMANY 86
10.3.1.1 Germany holds the largest share of the European market 86
TABLE 50 GERMANY: CELL THERAPY TECHNOLOGIES MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 86
TABLE 51 GERMANY: CELL THERAPY TECHNOLOGIES MARKET, BY PROCESS,
2018–2025 (USD MILLION) 87
TABLE 52 GERMANY: CELL THERAPY TECHNOLOGIES MARKET, BY CELL TYPE,
2018–2025 (USD MILLION) 87
TABLE 53 GERMANY: CELL THERAPY TECHNOLOGIES MARKET, BY END USER,
2018–2025 (USD MILLION) 87
10.3.2 UK 88
10.3.2.1 Favorable funding and investment scenario in the UK indicates strong growth in the coming years 88
TABLE 54 UK: CELL THERAPY TECHNOLOGIES MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 88
TABLE 55 UK: CELL THERAPY TECHNOLOGIES MARKET, BY PROCESS,
2018–2025 (USD MILLION) 88
TABLE 56 UK: CELL THERAPY TECHNOLOGIES MARKET, BY CELL TYPE,
2018–2025 (USD MILLION) 89
TABLE 57 UK: CELL THERAPY TECHNOLOGIES MARKET, BY END USER,
2018–2025 (USD MILLION) 89
10.3.3 FRANCE 89
10.3.3.1 Availability of government and private support is a key
driver of market growth 89
TABLE 58 FRANCE: CELL THERAPY TECHNOLOGIES MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 90
TABLE 59 FRANCE: CELL THERAPY TECHNOLOGIES MARKET, BY PROCESS,
2018–2025 (USD MILLION) 90
TABLE 60 FRANCE: CELL THERAPY TECHNOLOGIES MARKET, BY CELL TYPE,
2018–2025 (USD MILLION) 90
TABLE 61 FRANCE: CELL THERAPY TECHNOLOGIES MARKET, BY END USER,
2018–2025 (USD MILLION) 91
10.3.4 ITALY 91
10.3.4.1 Initiatives favoring cell and gene therapy development will support the market in Italy 91
TABLE 62 ITALY: CELL THERAPY TECHNOLOGIES MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 91
TABLE 63 ITALY: CELL THERAPY TECHNOLOGIES MARKET, BY PROCESS,
2018–2025 (USD MILLION) 92
TABLE 64 ITALY: CELL THERAPY TECHNOLOGIES MARKET, BY CELL TYPE,
2018–2025 (USD MILLION) 92
TABLE 65 ITALY: CELL THERAPY TECHNOLOGIES MARKET, BY END USER,
2018–2025 (USD MILLION) 92
10.3.5 SPAIN 93
10.3.5.1 Increasing funding from private and public organizations to
aid market growth 93
TABLE 66 SPAIN: CELL THERAPY TECHNOLOGIES MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 93
TABLE 67 SPAIN: CELL THERAPY TECHNOLOGIES MARKET, BY PROCESS,
2018–2025 (USD MILLION) 93
TABLE 68 SPAIN: CELL THERAPY TECHNOLOGIES MARKET, BY CELL TYPE,
2018–2025 (USD MILLION) 94
TABLE 69 SPAIN: CELL THERAPY TECHNOLOGIES MARKET, BY END USER,
2018–2025 (USD MILLION) 94
10.3.6 REST OF EUROPE 94
TABLE 70 ROE: CELL THERAPY TECHNOLOGIES MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 95
TABLE 71 ROE: CELL THERAPY TECHNOLOGIES MARKET, BY PROCESS,
2018–2025 (USD MILLION) 95
TABLE 72 ROE: CELL THERAPY TECHNOLOGIES MARKET, BY CELL TYPE,
2018–2025 (USD MILLION) 95
TABLE 73 ROE: CELL THERAPY TECHNOLOGIES MARKET, BY END USER,
2018–2025 (USD MILLION) 95
10.4 ASIA PACIFIC 96
FIGURE 22 ASIA PACIFIC: CELL THERAPY TECHNOLOGIES MARKET SNAPSHOT 96
TABLE 74 ASIA PACIFIC: CELL THERAPY TECHNOLOGIES MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 97
TABLE 75 ASIA PACIFIC: CELL THERAPY TECHNOLOGIES MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 97
TABLE 76 ASIA PACIFIC: CELL THERAPY EQUIPMENT MARKET, BY TYPE,
2018–2025 (USD MILLION) 97
TABLE 77 ASIA PACIFIC: CELL THERAPY TECHNOLOGIES MARKET, BY PROCESS,
2018–2025 (USD MILLION) 98
TABLE 78 ASIA PACIFIC: CELL THERAPY TECHNOLOGIES MARKET, BY CELL TYPE,
2018–2025 (USD MILLION) 98
TABLE 79 ASIA PACIFIC: CELL THERAPY TECHNOLOGIES MARKET, BY END USER,
2018–2025 (USD MILLION) 98
10.4.1 CHINA 99
10.4.1.1 Increasing cell therapy-based trials to support market
growth in China 99
TABLE 80 CHINA: CELL THERAPY TECHNOLOGIES MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 99
TABLE 81 CHINA: CELL THERAPY TECHNOLOGIES MARKET, BY PROCESS,
2018–2025 (USD MILLION) 100
TABLE 82 CHINA: CELL THERAPY TECHNOLOGIES MARKET, BY CELL TYPE,
2018–2025 (USD MILLION) 100
TABLE 83 CHINA: CELL THERAPY TECHNOLOGIES MARKET, BY END USER,
2018–2025 (USD MILLION) 100
10.4.2 JAPAN 101
10.4.2.1 Rising geriatric population and growing disease prevalence will drive the market in Japan 101
TABLE 84 JAPAN: CANCER INCIDENCE, BY TYPE, 2018 VS. 2025 101
TABLE 85 JAPAN: CELL THERAPY TECHNOLOGIES MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 102
TABLE 86 JAPAN: CELL THERAPY TECHNOLOGIES MARKET, BY PROCESS,
2018–2025 (USD MILLION) 102
TABLE 87 JAPAN: CELL THERAPY TECHNOLOGIES MARKET, BY CELL TYPE,
2018–2025 (USD MILLION) 102
TABLE 88 JAPAN: CELL THERAPY TECHNOLOGIES MARKET, BY END USER,
2018–2025 (USD MILLION) 103
10.4.3 AUSTRALIA 103
10.4.3.1 Market in Australia to benefit from rising investments in medicine 103
TABLE 89 AUSTRALIA: CELL THERAPY TECHNOLOGIES MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 103
TABLE 90 AUSTRALIA: CELL THERAPY TECHNOLOGIES MARKET, BY PROCESS,
2018–2025 (USD MILLION) 104
TABLE 91 AUSTRALIA: CELL THERAPY TECHNOLOGIES MARKET, BY CELL TYPE,
2018–2025 (USD MILLION) 104
TABLE 92 AUSTRALIA: CELL THERAPY TECHNOLOGIES MARKET, BY END USER,
2018–2025 (USD MILLION) 104
10.4.4 REST OF ASIA PACIFIC 104
TABLE 93 ROAPAC: CELL THERAPY TECHNOLOGIES MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 105
TABLE 94 ROAPAC: CELL THERAPY TECHNOLOGIES MARKET, BY PROCESS,
2018–2025 (USD MILLION) 105
TABLE 95 ROAPAC: CELL THERAPY TECHNOLOGIES MARKET, BY CELL TYPE,
2018–2025 (USD MILLION) 105
TABLE 96 ROAPAC: CELL THERAPY TECHNOLOGIES MARKET, BY END USER,
2018–2025 (USD MILLION) 106
10.5 REST OF THE WORLD 107
TABLE 97 ROW: CELL THERAPY TECHNOLOGIES MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 107
TABLE 98 ROW: CELL THERAPY EQUIPMENT MARKET, BY TYPE,
2018–2025 (USD MILLION) 107
TABLE 99 ROW: CELL THERAPY TECHNOLOGIES MARKET, BY PROCESS,
2018–2025 (USD MILLION) 108
TABLE 100 ROW: CELL THERAPY TECHNOLOGIES MARKET, BY CELL TYPE,
2018–2025 (USD MILLION) 108
TABLE 101 ROW: CELL THERAPY TECHNOLOGIES MARKET, BY END USER,
2018–2025 (USD MILLION) 108
11 COMPETITIVE LANDSCAPE & COMPANY PROFILES 109
11.1 COMPETITIVE LANDSCAPE 109
11.1.1 OVERVIEW 109
FIGURE 23 KEY DEVELOPMENTS IN THE CELL THERAPY TECHNOLOGIES MARKET, JANUARY 2017–SEPTEMBER 2020 109
FIGURE 24 MARKET EVOLUTION FRAMEWORK: JANUARY 2017 TO SEPTEMBER 2020 110
11.1.2 COMPETITIVE SCENARIO 111
11.1.2.1 Agreements, Collaborations, and Partnerships 111
TABLE 102 KEY AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS,
JANUARY 2017−SEPTEMBER 2020 111
11.1.2.2 Product Launches & Approvals 112
TABLE 103 KEY PRODUCT LAUNCHES AND APPROVALS,
JANUARY 2017−SEPTEMBER 2020 112
11.1.2.3 Expansions 112
TABLE 104 KEY EXPANSIONS, JANUARY 2017−SEPTEMBER 2020 112
11.1.2.4 Acquisitions 113
TABLE 105 KEY ACQUISITIONS, JANUARY 2017−SEPTEMBER 2020 113
11.1.2.5 Other Developments 114
TABLE 106 OTHER KEY DEVELOPMENTS, JANUARY 2017−SEPTEMBER 2020 114
11.1.3 MARKET SHARE ANALYSIS 115
FIGURE 25 CELL THERAPY TECHNOLOGIES MARKET SHARE ANALYSIS, 2019 115
11.1.4 COMPANY EVALUATION MATRIX 116
FIGURE 26 CELL THERAPY TECHNOLOGIES MARKET (GLOBAL) COMPANY
EVALUATION MATRIX, 2019 117
11.1.5 COMPETITIVE LEADERSHIP MAPPING (START-UPS) 118
FIGURE 27 CELL THERAPY TECHNOLOGIES MARKET: COMPETITIVE LEADERSHIP MAPPING (START-UPS), 2019 119
11.2 COMPANY PROFILES 120
(Business Overview, Products Offered, Recent Developments, and MnM View)*
11.2.1 THERMO FISHER SCIENTIFIC 120
FIGURE 28 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2019) 120
11.2.2 MERCK KGAA 125
FIGURE 29 MERCK KGAA: COMPANY SNAPSHOT (2019) 125
11.2.3 DANAHER CORPORATION 128
FIGURE 30 DANAHER CORPORATION: COMPANY SNAPSHOT (2019) 128
11.2.4 LONZA GROUP 131
FIGURE 31 LONZA GROUP: COMPANY SNAPSHOT (2019) 131
11.2.5 SARTORIUS AG 134
FIGURE 32 SARTORIUS AG: COMPANY SNAPSHOT (2019) 134
11.2.6 TERUMO BCT, INC. 137
FIGURE 33 TERUMO CORPORATION: COMPANY SNAPSHOT (2019) 137
11.2.7 BECTON, DICKINSON AND COMPANY 139
FIGURE 34 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2019) 139
11.2.8 FRESENIUS MEDICAL CARE AG & CO. KGAA 141
FIGURE 35 FRESENIUS MEDICAL CARE AG & CO. KGAA: COMPANY SNAPSHOT (2019) 141
11.2.9 AVANTOR, INC. 143
FIGURE 36 AVANTOR, INC.: COMPANY SNAPSHOT (2019) 143
11.2.10 BIO-TECHNE CORPORATION 145
FIGURE 37 BIO-TECHNE CORPORATION: COMPANY SNAPSHOT (2020) 145
11.2.11 CORNING INCORPORATED 147
FIGURE 38 CORNING: COMPANY SNAPSHOT (2019) 147
11.2.12 FUJIFILM IRVINE SCIENTIFIC 149
FIGURE 39 FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT (2019) 149
11.2.13 MAXCYTE 151
FIGURE 40 MAXCYTE: COMPANY SNAPSHOT (2019) 151
11.2.14 WERUM IT SOLUTIONS GMBH 153
FIGURE 41 KÖRBER AG: COMPANY SNAPSHOT (2019) 153
11.2.15 ROOSTERBIO 155
11.2.16 SIRION BIOTECH GMBH 156
11.2.17 CELLGENIX GMBH 157
11.2.18 L7 INFORMATICS 158
11.2.19 MILTENYI BIOTEC GMBH 159
11.2.20 STEMCELL TECHNOLOGIES 161
* Business Overview, Products Offered, Recent Developments, and MnM View might not be captured in case of unlisted companies.
11.2.21 HEMASOFT 163
11.2.22 MAK-SYSTEM 163
11.2.23 ORGANABIO, LLC 164
11.2.24 IXCELLS BIOTECHNOLOGY 164
11.2.25 WILSON WOLF CORPORATION 165
12 APPENDIX 166
12.1 INDUSTRY INSIGHTS 166
12.2 DISCUSSION GUIDE 167
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 170
12.4 AVAILABLE CUSTOMIZATIONS 172
12.5 RELATED REPORTS 172
12.6 AUTHOR DETAILS 173



★調査レポート[細胞治療技術の世界市場予測(~2025):製品別、プロセス別、細胞種類別、エンドユーザー別] ( Cell Therapy Technologies Market by Product (Consumables, Equipment (Single-Use Equipment, Other Equipment), Systems & Software), Process (Cell Processing), Cell Type (T-cells, Stem Cells), End User (Research Institutes) - Global Forecast to 2025 / BT 6823) 販売に関する免責事項
[細胞治療技術の世界市場予測(~2025):製品別、プロセス別、細胞種類別、エンドユーザー別] ( Cell Therapy Technologies Market by Product (Consumables, Equipment (Single-Use Equipment, Other Equipment), Systems & Software), Process (Cell Processing), Cell Type (T-cells, Stem Cells), End User (Research Institutes) - Global Forecast to 2025 / BT 6823) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆